Sulfuric Acid

Sulfuric Acid

SCHEMBL5215926

O=S(=O)([O-])O.Oc1ccc(CC2CCNCC2)cc1F.[H+]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.41
SLC6A4 P31645 3/20 0.40
PROKR1 Q8TCW9 3/20 0.36
FPR2 P25090 2/20 0.36
P2RX7 Q99572 1/20 0.36
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
KCNH2 Q12809 1/20 0.34
ACHE P22303 1/20 0.34
NMT1 P30419 1/20 0.34
PTPN1 P18031 1/20 0.33
GRIN2B Q13224 1/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL5215916 0.93 GBA1 (0.44) GBA1SLC6A4PROKR1FPR2P2RX7
SCHEMBL5215583 0.89 GBA1 (0.50) GBA1SLC6A4P2RX7ACHEPTPN1
Sulfuric Acid SCHEMBL5217718 0.81 GBA1 (0.51) GBA1SLC6A4GRIN2B
SCHEMBL12776090 0.76 GBA1 (0.55) GBA1SLC6A4
SCHEMBL717183 0.76 GBA1 (0.55) GBA1SLC6A4P2RX7PRMT5WDR77
Hydrochloric Acid SCHEMBL7405591 0.74 GBA1 (0.53) GBA1SLC6A4P2RX7PRMT5WDR77
Sulfuric Acid SCHEMBL5217713 0.73 GBA1 (0.56) GBA1SLC6A4GRIN2B
SCHEMBL5362096 0.73 TBXA2R (0.56) GBA1SLC6A4
SCHEMBL14747890 0.72 GBA1 (0.50) GBA1SLC6A4PROKR1FPR2P2RX7
SCHEMBL16365283 0.72 GBA1 (0.50) GBA1SLC6A4PROKR1FPR2P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1330460-B1 BENZOXAZINONE DERIVATIVES, THEIR PREPARATION AND USE SMITHKLINE BEECHAM PLC (GB) 2007-03-21 EP disclosed
US-6939871-B2 Benzoxazinone derivatives, their preparation and use SMITHKLINE BEECHAM P.L.C. (GB) 2005-09-06 US disclosed
US-20040063704-A1 Benzoxazinone derivatives, their preparation and use SMITHKLINE BEECHAM P.L.C (GB) 2004-04-01 US disclosed
EP-1330460-A2 BENZOXAZINONE DERIVATIVES, THEIR PREPARATION AND USE SMITHKLINE BEECHAM PLC (GB) 2003-07-30 EP disclosed
WO-2002034754-A2 BENZOXAZINONE DERIVATIVES, THEIR PREPARATION AND USE SMITHKLINE BEECHAM P.L.C. (GB) 2002-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063704-A1 Benzoxazinone derivatives, their preparation and use CYP2B6, CBR1, CYP2A6 GBA1 437/4885SLC6A4 1029/4885PROKR1 3029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.